MYX News: Shawn O’Brien Buys Handful Of Shares In Mayne Pharma Group - 29th Oct 2023, 9:06am

[annb0t]

Even if it's not a huge purchase, we think it was good to see that Shawn O’Brien, the CEO, MD & Director of Mayne Pharma Group Limited (ASX:MYX) recently shelled out AU$141k to buy stock, at AU$3.80 per share. Nevertheless, it only increased their shareholding by a minuscule percentage, and it wasn't a massive purchase by absolute value, either.

Check out our latest analysis for Mayne Pharma Group

Mayne Pharma Group Insider Transactions Over The Last Year

In fact, the recent purchase by ...

>>> Read more: Shawn O’Brien Buys Handful Of Shares In Mayne Pharma Group